Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data

Background: Improve the treatment quality might affect patients’ efficacy and survival. Methods: Five hundred thirty multiple myeloma patients treated in four hematological centers in China from February 2006 to August 2018 were enrolled. General characteristics, treatment regimens and cycles, effic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: He, Jingsong, He, Donghua, Han, Xiaoyan, Zheng, Gaofeng, Wei, Guoqing, Zhao, Yi, Yang, Yang, Wu, Wenjun, Fu, Jiaping, Shou, Lihong, Kong, Hongwei, Huang, He, Cai, Zhen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7759685/
https://ncbi.nlm.nih.gov/pubmed/33362538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.561601
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados